Application
Western blot analysis of extracts from EGF-treated 293 and PMA-treated HUVEC cells using PKD/PKC mu (Phospho-Ser910) Antibody .Application
Immunofluorescence staining of methanol-fixed Hela cells using PKD/PKCm (Phospho-Ser910)Application
Western blot analysis of extracts from EGF-treated 293 and PMA-treated HUVEC cells using PKD/PKCm(Phospho-Ser910)| Product Name | PKC mu (phospho Ser910) antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit Polyclonal antibody to PKC mu (Phospho Ser910)Converts transient diacylglycerol. (DAG) signals into prolonged physiological effects, downstream of PKC. Involved in resistance to oxidative stress through activation of NF-kappa-B. |
| Immunogen | Peptide sequence around phosphorylation site of serine 910 (R-V-S(p)-I-L) derived from Human PKD/PKC mu . |
| Modification | p-Ser910 |
| Clonality | Polyclonal |
|---|---|
| Host Species | Rabbit |
| Tested Applications | ICC/IFWB |
| Suggested starting dilutions are as follows. WB: 1:500~1:1000, ICC/IF: 1:100~1:200. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user. | |
| Species Reactivity | HumanMouseRat |
| Concentration | 1mg/ml (Please refer to the vial label for the specific concentration) |
| Purification | Affinity purified |
| Gene Synonyms | PKC-MU, PKCM, PKD, PRKCM, PRKD1, protein kinase C mu type, serine/threonine-protein kinase D1, protein kinase C, mu, nPKC-D1, protein kinase D, nPKC-mu, protein kinase D1 |
|---|---|
| Target | PKD/PKC mu (Phospho Ser910) |
| Molecular Weight(MW) | 115 (note) |
Application
Western blot analysis of extracts from EGF-treated 293 and PMA-treated HUVEC cells using PKD/PKC mu (Phospho-Ser910) Antibody .
Application
Immunofluorescence staining of methanol-fixed Hela cells using PKD/PKCm (Phospho-Ser910)
Application
Western blot analysis of extracts from EGF-treated 293 and PMA-treated HUVEC cells using PKD/PKCm(Phospho-Ser910)| Application Notes | Suggested starting dilutions are as follows. WB: 1:500~1:1000, ICC/IF: 1:100~1:200. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user. |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Keep as concentrated solution. Aliquot and store at -20oC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
